Microlife Microlife
  • Consumer Products
    • BP A7 Touch BT_half_cuff Blood Pressure
    • Multiplex_front Blood Glucose
    • NC200_front Thermometers
    • BreastPump_BC200-front Baby Care
    • NEB NANO_half-acc Respiratory Care
    • Microlife WS 80 front Weight
    • Software_downloads_allg Software
  • Professional Products
    • WatchBP Office ABI_front_cuff WatchBP Office
    • WatchBP O3 Ambulatory 2G_half_cuff WatchBP O3
    • WatchBP Home A_front_cuff WatchBP Home
    • Cuff-Ankle Cuffs and supplies
    • Software_downloads_WBP Software
  • Clinical Validations
  • Technologies
  • Health Magazine
    • icon_heart_blue Cardiovascular Health
    • icon_Temperature Fever Care
    • icon_airway-treatment Respiratory Care
    • icon_even_heat_blue Flexible Heating
  • Support
    • BP A2 Basic startseite Product Support
    • Software_downloads_allg Home-Use Software
    • Software Developers Developers
    • Software_downloads_WBP Professional Software
  • Company
    • aboutus About us
    • History History
    • Events News & Events
    • contact Contact
EUROPE
English
Europe
  • EUROPE - English
  • CZECHIA - Čeština
  • DANMARK - Dansk
  • DEUTSCHLAND - Deutsch
  • ESPAÑA - Español
  • FRANCE - Français
  • HRVATSKA - Hrvatski
  • ITALIA - Italiano
  • LATVIJA - Latviešu
  • LIETUVA - Lietuvių
  • MAGYARORSZÁG - Magyar
  • NEDERLAND - Nederlands
  • ÖSTERREICH - Deutsch
  • POLSKA - Polski
  • PORTUGAL - Português
  • SCHWEIZ - Deutsch
  • SLOVENSKO - Slovenčina
  • SLOVENIJA - Slovenščina
  • SUOMI - Suomi
  • SCHWEIZ - Français
  • UK - English
  • ΕΛΛΆΔΑ - Ελληνικά
  • БЪЛГАРИЯ - Български
  • СРБИЈА - Српски
  • УКРАЇНА - Українська
  • TÜRKIYE - Türkçe
  • РОССИЯ - Русский
  • БЕЛАРУСЬ - Русский
Asia
  • ASIA PACIFIC - English
  • VIỆT NAM - Tiếng Việt
  • ประเทศไทย - ไทย
  • 中国 - 中文
  • 台灣 - 中文
Middle East and North Africa
  • MENA - Arabic عربى
USA, Latin America
  • US - English
  • AMÉRICA DEL SUR - Español
  • COLOMBIA - Español
  • MÉXICO - Español
Menu
Header_WatchBP Validation-Diabetes Flow

Validation of the Microlife BP A3 PC upper arm blood pressure monitor in patients with diabetes mellitus according to the ANSI/AAMI/ISO 81060-2:2013 protocol

Home > Professional Products > Validations and clinical studies > Validation of the Microlife BP A3 PC upper arm blood pressure monitor in patients with diabetes mellitus according to the ANSI/AAMI/ISO 81060-2:2013 protocol, Beime, 2017
Share

Beate Beimea, Ralf Krügera, Gertrud Hammelb, Peter Bramlagea and Cornelia Deutscha

Objective

The aim of the present study was to validate the blood pressure (BP) measurement device, Microlife BP A3 PC, in patients with diabetes mellitus, according to the ANSI/AAMI/ISO 81060-2:2013 protocol.

Patients and methods

In 85 individuals aged 56–88 years, with predefined criteria for diabetes mellitus, BP measurements on the upper arm were performed alternately using the Microlife BP A3 PC and a standard mercury reference sphygmomanometer. A total of 333 comparisons were included for analysis.

Results

The mean difference between the Microlife BP A3 PC and the reference was −1.5± 6.3 mmHg for systolic BP (SBP) and −1.3± 5.2 mmHg for diastolic BP (DBP) according to criterion 1 of the protocol. For SBP, a total of 209 of the 333 measurements were within the range of 5 mmHg (62.8%), whereas the corresponding numbers for DBP were 232 of 333  (69.7%). For criterion 2, the intraindividual differences for the test device and the reference were −1.50± 4.73 mmHg for SBP and −1.30 ± 4.55 mmHg for DBP, thus being within the defined ranges provided by the protocol.

Conclusion

The Microlife BP A3 PC fulfilled the requirements of criteria 1 and 2 of the ANSI/AAMI/ISO 81060-2:2013 protocol and can also be recommended for BP measurement in diabetic patients.

Blood Press Monit 00:000–000 Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

Click here to download the abstract in pdf format.

Microlife
  • Support
  • Contact
  • Imprint
  • Privacy policy
  • Terms of use
Login
Copyright © 2025 - Microlife Corporation. All rights reserved.